Nano Hayat Darou

Nano Hayat Darou is an Iranian pharmaceutical company specializing in the development and production of advanced nanomedicine and drug delivery systems. The company focuses on high-tech oncology treatments, utilizing nanotechnology to improve the efficacy and safety profiles of established chemotherapeutic agents. Its flagship products include Paclinab, a nanoparticle albumin-bound paclitaxel, and Doxonab, a liposomal formulation of doxorubicin. Nano Hayat Darou operates a GMP-certified manufacturing facility and aims to provide affordable access to complex generic nanopharmaceuticals in the Middle East and beyond. The firm is recognized as a pioneer in the regional production of nano-drugs for life-threatening diseases.